Pharmaceutical Contract Packaging Market
Market Insights on Pharmaceutical Contract Packaging covering sales outlook, demand forecast & up-to-date key trends
Pharmaceutical contract packaging Market by Type, Form, Application & Region - Forecast 2022 – 2032
Pharmaceutical Contract Packaging Market Outlook (2022-2032)
[340 Pages Report] The global pharmaceutical contract packaging market is forecasted to be valued at US$ 11,586 Mn by 2032, up from US$ 5,674 Mn in 2022, projecting a CAGR of 7.4% during the forecast period.
|
Report Attribute |
Details |
|
Pharmaceutical Contract Packaging Market Value (2022) |
US$ 5,674 Mn |
|
Pharmaceutical Contract Packaging Market Anticipated Value (2032) |
US$ 11,586 Mn |
|
Pharmaceutical Contract Packaging Projected Growth Rate (2032) |
7.4% |
Rising prevalence of diseases such as diabetes and asthma due to the growing aging population is anticipated to fuel the pharmaceutical contract packaging market growth.
Establishing mutually beneficial relationships with Contract Packaging Organizations (CPOs) and Contract Development & Manufacturing (CDMOs) to avoid lack of resources and budgets is the pharmaceutical contract packaging market size. Furthermore, the adoption of pharmaceutical contract packaging is anticipated to rise owing to implementation of serialization that mandates the barcodes and transfer of large volumes of data in the supply of medicines.
The rising prevalence of atmosphere sensitive pharmaceutical drugs surged the demand for silica-based packaging material are some of the latest pharmaceutical contract packaging market trends. Moreover, witnessing a proliferation of the geriatric population in developed regions highly dependent on pharmaceutical drugs for maintaining good health is projected to boost the sales of pharmaceutical contract packaging.
Let us know your requirement to get
100% FREE customization
What are the Key Pharmaceutical Contract Packaging Market Dynamics?
The implementation of advanced manufacturing techniques and technological advancements, higher spending in public healthcare systems owing to population increase and health awareness are some of the major factors driving pharmaceutical contract packaging market growth.
Government execution of new regulations to control the spreading of contagious diseases, new treatments such as gene and cell therapies and growing demand for bio-products are some of the factors driving the adoption of pharmaceutical contract packaging.
Generic pharmaceuticals of lower cost increasing in popularity in developing economies as well as generic drugs requiring efficient packaging and protection during storage and shipping is projected to boost the demand for pharmaceutical contract packaging. The capability of vendors to take undertake several packaging projects, including sorting issues arising complex packaging requirements surges the adoption of pharmaceutical contract packaging.
Investment in R&D activities to enhance the quality of their services and meet consumer demands is anticipated to boost the pharmaceutical contract packaging market growth.
What are the Drawbacks of Pharmaceutical Contract Packaging?
Increasing risks associated with the poor quality of the product as well as fluctuating prices of raw materials used for manufacturing pharmaceutical packaging products are some of the factors anticipated to hamper the market growth. The availability of counterfeit medicines containing false or inactive ingredients across the globe, significantly hinders the global pharmaceutical contract packaging market growth.
Restricted information sharing with contract packages in fear of vulnerability as well as lack of expertise, in-house packaging capabilities and budget constraints further obstructs the pharmaceutical contract packaging market share.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat is the Scope of the Pharmaceutical Contract Packaging Market?
The pharmaceutical contract packaging market share is projected to rise owing to the increasing utilization of smart packaging solutions such as smart labels. Furthermore, R&D activities to develop advanced plastics and increase development of patient-specific implants and 3D printed devices drives the sales of pharmaceutical contract packaging.
Increasing demand for eco-friendly and reusable packaging in regards to environment sustainability as well as rise in the e-commerce industry allowing vendors to expand their business to a wider audience. A scale-oriented acquisition strategy represented owing to the merger between cloud packaging companies and their clientele, promotes the pharmaceutical contract packaging market growth.
Stakeholders re-shuffling their production activities to adapt to the demands of the healthcare infrastructures increases the global pharmaceutical contract packaging market share. Government agencies implementing stricter norms on packaging, as well as increasing consumer interest for innovative packaging fuels the demand for pharmaceutical contract packaging.
Regional Insights on the Pharmaceutical Contract Packaging Market
How is the Performance of the North America Pharmaceutical Contract Packaging Market?
North America accounts for the leading pharmaceutical contract packaging market share of 33%. Quality services offered by the CPOs and CDMOs based in the U.S. propels the demand for pharmaceutical contract packaging in the region. The demand for biological therapies, increase in strict protocols, and rise in the geriatric population broadens the global pharmaceutical contract packaging market size.
What is the Growth Outlook for the Europe Pharmaceutical Contract Packaging Market?
Europe holds a 28% revenue in the pharmaceutical contract packaging market share, and is the second most dominating market. Large presence of major manufacturers operating the pharmaceutical industry creates lucrative opportunities and increases the adoption of pharmaceutical contract packaging. Increasing use of pharmaceutical products such as plastic bottles and containers, vials & ampoules, and pre-fillable syringes are anticipated to boost the demand for pharmaceutical contract packaging in this region.
How is the Asia-Pacific Pharmaceutical Contract Packaging Market Outlook?
The Asia Pacific is anticipated to grow at highest CAGR in the pharmaceutical contract packaging market. Increasing demand for biological therapies and rigid protocols associated with packaging processes as well as the presence of several pharmaceutical contact packaging service providers in the region boost the overall market size.
The sales of pharmaceutical contract packaging is anticipated to rise owing to the rapid outsourcing of pharmaceutical manufacturing to emerging countries, such as India.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
How is the Start-up Ecosystem in the Pharmaceutical Contract Packaging Market?
To protect pharmaceutical products better than conventional materials, startups in the pharmaceutical contract packaging strive to develop enhanced packaging solutions.
Exposure to heat, light, air, and moisture can negatively affect the efficacy of pharmaceutical products, as they are highly reactive. Medical products have to be kept at or below room temperature and isolated using containers. However, a significant amount of medicine wastage can be the result of low-quality packaging and poor handling as well.
Hence, some start-up companies such as Veneti, Unipharm Healthy Manufacturing, V-Shapes, Blistr, Calyx Containers, etc. are coming up with various strategies to improve the pharmaceutical contract packaging market share, like medical cannabis containers, biodegradable pharma packaging, single-portion packets, contract pharmaceuticals packaging with labelling and distribution, etc.
This is changing the landscape of pharmaceutical contact packaging and generating newer and more innovative ideas to tackle every challenge.
Competition Landscape of the Pharmaceutical Contract Packaging Market
Improving pharmaceutical packaging so that it can withstand adverse environmental conditions is a major priority for key players in the pharmaceutical contract packaging market share.
Some of the key players of the pharmaceutical contract packaging market are Catalent Pharma Solutions, Patheon, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, Pfizer CentreSource, Daito Pharmaceutical, Nipro Corporation, Becton Dickinson & Company, AptarGroup Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois Inc., WestRock Company SGD S.A., International Paper Company, COMAR LLC, CCL Industries Inc., Vetter Pharma International, Adelphi Healthcare Packaging, Sharp Corporation, Amcor Limited, Berry Plastics Corporation, MeadWestvaco Corporation, Becton Dickinson and Company, Owens-Illinois Inc., West Pharmaceuticals Services Inc., Schott Pharmaceuticals Services Inc., RPC Group Plc, Graphic Packaging International Inc., etc.
Some of the recent developments in the pharmaceutical contract packaging are:
- In January 2021, Nelipak Laboratory Services completed the collaboration of a new climatic conditioning compartment to meet the amplified demand for conditioning.
- In December 2020, ProAmpac acquired Rosenbloom Groupe Inc., Hymopack Ltd., and Dyne-A-Pak, based in Canada that manufacture packaging products, to enhance the manufacturing capabilities of the company.
- In May 2021, Sharp - a clinical services company owned by UDG Healthcare plc, purchased new land as part of a US$ 17 Mn investment in its Conshohocken, PA, to add future capacity for cGMP packaging services.
- In June 2020, PCI Pharma announced a partnership agreement with Experic, to explore clinical and commercial manufacturing, packaging, and supply chain services driving collective growth for both parties.
Table:
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 7.4% from 2022 to 2032 |
|
Base year for estimation |
2021 |
|
Historical data |
2016 - 2021 |
|
Forecast period |
2022 - 2032 |
|
Quantitative units |
Revenue in USD million and CAGR from 2022 to 2032 |
|
Report coverage |
Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
|
Segments covered |
Type, Form, Application, and Region. |
|
Regional scope |
North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
|
Country scope |
U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
|
Key companies profiled |
Catalent Pharma Solutions, Patheon, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, Pfizer CentreSource, Daito Pharmaceutical, Nipro Corporation, Becton Dickinson & Company, AptarGroup Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois Inc., WestRock Company SGD S.A., International Paper Company, COMAR LLC, CCL Industries Inc., Vetter Pharma International, Adelphi Healthcare Packaging, Sharp Corporation, Amcor Limited, Berry Plastics Corporation, MeadWestvaco Corporation, Becton Dickinson and Company, Owens-Illinois Inc., West Pharmaceuticals Services Inc., Schott Pharmaceuticals Services Inc., RPC Group Plc, Graphic Packaging International Inc., etc. |
|
Customization scope |
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. |
Key Segments
By Type:
- Flexible Packaging
- Plastic/Glass Containers
- Caps/Closures
By Form:
- Oral
- Injectable
By Application:
- Autacoids & Related Drugs
- Contraceptives
- Hormone Replacement
- Cardiovascular Medicines
- Cancer Therapies
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Frequently Asked Questions
The pharmaceutical contract packaging market is predicted to garner a CAGR of 7.4% through 2032.
The pharmaceutical contract packaging market is expected to surpass US$ 11,586 Mn by 2032.
North America dominates the pharmaceutical contract packaging market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2022-2032
5.3.1. Flexible Packaging
5.3.2. Plastic Containers
5.3.3. Glass Containers
5.3.4. Caps/Closures
5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type, 2022-2032
6.3.1. Autacoids & Related Drugs
6.3.2. Contraceptives
6.3.3. Hormone Replacement
6.3.4. Cardiovascular Medicines
6.3.5. Cancer Therapies
6.4. Y-o-Y Growth Trend Analysis By Drug Type, 2017-2021
6.5. Absolute $ Opportunity Analysis By Drug Type, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Form
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Drug Form, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Form, 2022-2032
7.3.1. Oral
7.3.2. Injectable
7.4. Y-o-Y Growth Trend Analysis By Drug Form, 2017-2021
7.5. Absolute $ Opportunity Analysis By Drug Form, 2022-2032
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Drug Type
9.2.4. By Drug Form
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Drug Type
9.3.4. By Drug Form
9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Drug Type
10.2.4. By Drug Form
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Drug Type
10.3.4. By Drug Form
10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Drug Type
11.2.4. By Drug Form
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Drug Type
11.3.4. By Drug Form
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Malaysia
12.2.1.6. Singapore
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of APAC
12.2.2. By Product
12.2.3. By Drug Type
12.2.4. By Drug Form
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Drug Type
12.3.4. By Drug Form
12.4. Key Takeaways
13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product
13.2.3. By Drug Type
13.2.4. By Drug Form
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Drug Type
13.3.4. By Drug Form
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product
14.1.2.2. By Drug Type
14.1.2.3. By Drug Form
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product
14.2.2.2. By Drug Type
14.2.2.3. By Drug Form
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product
14.3.2.2. By Drug Type
14.3.2.3. By Drug Form
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product
14.4.2.2. By Drug Type
14.4.2.3. By Drug Form
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product
14.5.2.2. By Drug Type
14.5.2.3. By Drug Form
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Product
14.6.2.2. By Drug Type
14.6.2.3. By Drug Form
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Product
14.7.2.2. By Drug Type
14.7.2.3. By Drug Form
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Product
14.8.2.2. By Drug Type
14.8.2.3. By Drug Form
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Product
14.9.2.2. By Drug Type
14.9.2.3. By Drug Form
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Product
14.10.2.2. By Drug Type
14.10.2.3. By Drug Form
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Product
14.11.2.2. By Drug Type
14.11.2.3. By Drug Form
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Product
14.12.2.2. By Drug Type
14.12.2.3. By Drug Form
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Product
14.13.2.2. By Drug Type
14.13.2.3. By Drug Form
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Product
14.14.2.2. By Drug Type
14.14.2.3. By Drug Form
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Product
14.15.2.2. By Drug Type
14.15.2.3. By Drug Form
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Product
14.16.2.2. By Drug Type
14.16.2.3. By Drug Form
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Product
14.17.2.2. By Drug Type
14.17.2.3. By Drug Form
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Product
14.18.2.2. By Drug Type
14.18.2.3. By Drug Form
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Product
14.19.2.2. By Drug Type
14.19.2.3. By Drug Form
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product
15.3.3. By Drug Type
15.3.4. By Drug Form
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Catalent Pharma Solutions
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Patheon
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Baxter BioPharma Solutions
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. AbbVie Contract Manufacturing
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Pfizer CentreSource
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Daito Pharmaceutical
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Nipro Corporation
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. BALL CORPORATION
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Amcor plc
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. WestRock Company
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 3: Global Market Value (US$ Mn) Forecast by Drug Type, 2017-2032
Table 4: Global Market Value (US$ Mn) Forecast by Drug Form, 2017-2032
Table 5: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 6: North America Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 7: North America Market Value (US$ Mn) Forecast by Drug Type, 2017-2032
Table 8: North America Market Value (US$ Mn) Forecast by Drug Form, 2017-2032
Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 11: Latin America Market Value (US$ Mn) Forecast by Drug Type, 2017-2032
Table 12: Latin America Market Value (US$ Mn) Forecast by Drug Form, 2017-2032
Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 15: Europe Market Value (US$ Mn) Forecast by Drug Type, 2017-2032
Table 16: Europe Market Value (US$ Mn) Forecast by Drug Form, 2017-2032
Table 17: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: Asia Pacific Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 19: Asia Pacific Market Value (US$ Mn) Forecast by Drug Type, 2017-2032
Table 20: Asia Pacific Market Value (US$ Mn) Forecast by Drug Form, 2017-2032
Table 21: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: MEA Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 23: MEA Market Value (US$ Mn) Forecast by Drug Type, 2017-2032
Table 24: MEA Market Value (US$ Mn) Forecast by Drug Form, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Product, 2022-2032
Figure 2: Global Market Value (US$ Mn) by Drug Type, 2022-2032
Figure 3: Global Market Value (US$ Mn) by Drug Form, 2022-2032
Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 11: Global Market Value (US$ Mn) Analysis by Drug Type, 2017-2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032
Figure 14: Global Market Value (US$ Mn) Analysis by Drug Form, 2017-2032
Figure 15: Global Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032
Figure 17: Global Market Attractiveness by Product, 2022-2032
Figure 18: Global Market Attractiveness by Drug Type, 2022-2032
Figure 19: Global Market Attractiveness by Drug Form, 2022-2032
Figure 20: Global Market Attractiveness by Region, 2022-2032
Figure 21: North America Market Value (US$ Mn) by Product, 2022-2032
Figure 22: North America Market Value (US$ Mn) by Drug Type, 2022-2032
Figure 23: North America Market Value (US$ Mn) by Drug Form, 2022-2032
Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 31: North America Market Value (US$ Mn) Analysis by Drug Type, 2017-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032
Figure 34: North America Market Value (US$ Mn) Analysis by Drug Form, 2017-2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032
Figure 37: North America Market Attractiveness by Product, 2022-2032
Figure 38: North America Market Attractiveness by Drug Type, 2022-2032
Figure 39: North America Market Attractiveness by Drug Form, 2022-2032
Figure 40: North America Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Market Value (US$ Mn) by Product, 2022-2032
Figure 42: Latin America Market Value (US$ Mn) by Drug Type, 2022-2032
Figure 43: Latin America Market Value (US$ Mn) by Drug Form, 2022-2032
Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 51: Latin America Market Value (US$ Mn) Analysis by Drug Type, 2017-2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032
Figure 54: Latin America Market Value (US$ Mn) Analysis by Drug Form, 2017-2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032
Figure 57: Latin America Market Attractiveness by Product, 2022-2032
Figure 58: Latin America Market Attractiveness by Drug Type, 2022-2032
Figure 59: Latin America Market Attractiveness by Drug Form, 2022-2032
Figure 60: Latin America Market Attractiveness by Country, 2022-2032
Figure 61: Europe Market Value (US$ Mn) by Product, 2022-2032
Figure 62: Europe Market Value (US$ Mn) by Drug Type, 2022-2032
Figure 63: Europe Market Value (US$ Mn) by Drug Form, 2022-2032
Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 71: Europe Market Value (US$ Mn) Analysis by Drug Type, 2017-2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032
Figure 74: Europe Market Value (US$ Mn) Analysis by Drug Form, 2017-2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032
Figure 77: Europe Market Attractiveness by Product, 2022-2032
Figure 78: Europe Market Attractiveness by Drug Type, 2022-2032
Figure 79: Europe Market Attractiveness by Drug Form, 2022-2032
Figure 80: Europe Market Attractiveness by Country, 2022-2032
Figure 81: Asia Pacific Market Value (US$ Mn) by Product, 2022-2032
Figure 82: Asia Pacific Market Value (US$ Mn) by Drug Type, 2022-2032
Figure 83: Asia Pacific Market Value (US$ Mn) by Drug Form, 2022-2032
Figure 84: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032
Figure 85: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: Asia Pacific Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 91: Asia Pacific Market Value (US$ Mn) Analysis by Drug Type, 2017-2032
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032
Figure 94: Asia Pacific Market Value (US$ Mn) Analysis by Drug Form, 2017-2032
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032
Figure 97: Asia Pacific Market Attractiveness by Product, 2022-2032
Figure 98: Asia Pacific Market Attractiveness by Drug Type, 2022-2032
Figure 99: Asia Pacific Market Attractiveness by Drug Form, 2022-2032
Figure 100: Asia Pacific Market Attractiveness by Country, 2022-2032
Figure 101: MEA Market Value (US$ Mn) by Product, 2022-2032
Figure 102: MEA Market Value (US$ Mn) by Drug Type, 2022-2032
Figure 103: MEA Market Value (US$ Mn) by Drug Form, 2022-2032
Figure 104: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 105: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: MEA Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 109: MEA Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 110: MEA Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 111: MEA Market Value (US$ Mn) Analysis by Drug Type, 2017-2032
Figure 112: MEA Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032
Figure 113: MEA Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032
Figure 114: MEA Market Value (US$ Mn) Analysis by Drug Form, 2017-2032
Figure 115: MEA Market Value Share (%) and BPS Analysis by Drug Form, 2022-2032
Figure 116: MEA Market Y-o-Y Growth (%) Projections by Drug Form, 2022-2032
Figure 117: MEA Market Attractiveness by Product, 2022-2032
Figure 118: MEA Market Attractiveness by Drug Type, 2022-2032
Figure 119: MEA Market Attractiveness by Drug Form, 2022-2032
Figure 120: MEA Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Packaging Insights
View Reports
